Please assess the completion status of the following clinical trial:

Trial Title: Perioperative Dexamethasone on Postoperative Outcome in IBD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients undergoing elective open and laparoscopic small and large bowel operations for IBD, including Crohn's Disease(CD) and Ulcerative Colitis (UC).~2. ASA I-III~Exclusion Criteria:~1. Diabetes or hyperglycemia~2. Active gastric ulceration confirmed endoscopically~3. Presence of ongoing infection (such as IAS) or infective chronic diseases~4. Currently receiving systemic therapy with glucocorticoids with prednisolone \>=20mg for over 6 weeks within 30 days prior to surgery.~5. Emergent surgery~6. Acute angle glaucoma~7. Pregnancy~8. Under 18 years of age~9. Known adverse reaction to dexamethasone~10. Extensive adhesiolysis~11. Carcinogenesis of intestinal tract

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Dexamethasone (Type: EXPERIMENTAL): Dexamethasone 8mg intravenously prior to anesthesia induction
- Control (Type: PLACEBO_COMPARATOR): Normal Saline 1.6ml intravenously prior to anesthesia induction

Based on this trial design, predict the completion outcome and termination type (if applicable).